Showing results (101-110 of 158) with videos related to
Sort By:
Pageof 16
The Journal of Antimicrobial Chemotherapy|October 1, 1984
Evaluation of the antirhinovirus chalcone Ro 09-0415 given orally to volunteersR J Phillpotts, P G Higgins, J S Willman, et al.The Journal of Hygiene|April 1, 1978
Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2)H E Larson, D A Tyrrell, C H Bowker, et al.The European Respiratory Journal|March 1, 1992
Bronchial reactivity to histamine and bradykinin is unchanged after rhinovirus infection in normal subjectsQ A Summers, P G Higgins, I G Barrow, et al.Journal of Psychopharmacology (Oxford, England)|January 28, 2012
Effects of zinc gluconate and nedocromil sodium on performance deficits produced by the common coldA P Smith, D A Tyrrell, W Al-Nakib, et al.British Medical Journal (Clinical Research Ed.)|April 25, 1981
Toxicity of interferonG M Scott, D S Secher, D Flowers, et al.The Journal of Hygiene|December 1, 1973
An outbreak of common colds at an Antarctic base after seventeen weeks of complete isolationT R Allen, A F Bradburne, E J Stott, et al.Journal of Clinical Pathology|May 1, 1985
United Kingdom scheme for external quality assessment in virology. Part I. General method of operationS E Reed, P S Gardner, J J Snell, et al.British Medical Journal (Clinical Research Ed.)|June 19, 1982
Purified interferon as protection against rhinovirus infectionG M Scott, R J Phillpotts, J Wallace, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1987
Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteersW Al-Nakib, P G Higgins, I Barrow, et al.Journal of Interferon Research|January 1, 1980
Skin reactions to interferon inoculations are reduced but not abolished by purificationG M Scott, W E Stewart, D A Tyrrell, et al.Pageof 16